St. Luke's Hospital, Chesterfield, Missouri   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Chesterfield MO United States (1866)

Organization Overview

First Clinical Trial
2007
NCT00506974
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

St. Luke's Hospital, Chesterfield, Missouri

Active Ingredients

Drugs in Phase 4 Trials (5)

sodium chloride (1 trial)

sodium oxybate (xyrem) (1 trial)

vancomycin (Vancocin) (1 trial)

zaleplon (sonata) (1 trial)

zolpidem (ambien) (1 trial)

Drugs in Phase 2 Trials (2)

arginine (1 trial)

ringer's lactate (1 trial)

Drugs in Other Trials (1)

oxygen (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atherosclerosis (Phase 2)

Clostridium Infections (Phase 4)

Communicable Diseases (Phase 4)

Infections (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 8